NurExone’s Intellectual Property Portfolio Expands NurExone's Intellectual Property portfolio is expanding to encompass processes and compositions related to exosomes in large-scale production

NurExone Launches Licensing Efforts for ExoTherapy Platform NurExone Biologic launches licensing efforts for its ExoTherapy platform for creating nanodrugs by loading therapeutic molecular cargo into exosomes.